Clinical trial
Human Fibrinogen - Pharmacokinetics
NCT00496262 · CSL Behring, Industry · Completed
Key facts
| NCT number | NCT00496262 |
|---|---|
| Title | Human Fibrinogen - Pharmacokinetics |
| Official title | Pharmacokinetics of Haemocomplettan® P in Subjects With Congenital Fibrinogen Deficiency |
| Lead sponsor | CSL Behring, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fibrinogen Deficiency |
| Intervention type | Biological |
| Interventions | Human Fibrinogen Concentrate |
| Enrollment | 15 |
| Start date | Jul 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jul 4, 2007 |
| Last update posted | Sep 15, 2016 |
| Countries | Italy, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: